Revolutionary AI-Powered Wearable for Breast Cancer Screening Unveiled

Lord's Mark Industries Limited partners with CMET to develop a non-radiative, AI-powered breast screening wearable. This device aims to enhance early detection of breast cancer, offering a convenient and scalable solution. The initiative bolsters India's healthcare innovation and presents a promising global screening alternative.

In a significant advancement in medical technology, Lord's Mark Industries Limited has formed a strategic partnership with the Centre for Materials for Electronic Technology (CMET) to produce an innovative, AI-powered breast screening wearable device. This device aims to revolutionize early breast cancer detection by offering a non-radiative, painless screening alternative.

India positions itself as a leader in healthcare innovation with this breakthrough, addressing a crucial need for safer and more accessible screening options. The wearable integrates high-precision thermal sensors with AI-driven analytics, providing reliable early-stage abnormality detection. By eliminating radiation exposure and expanding usability beyond traditional medical settings, the device promises to increase compliance and convenience for users.

This initiative marks a pivotal step in Lord's Mark's commitment to leveraging technology for health, supporting women across India with empowering, intelligent, and cost-effective screening solutions. With commercialization targeted by year's end, the company aims to extend its impact globally, setting a new benchmark for preventive diagnostics in the healthcare sector.